Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fukuda Denshi Co's Other Operating Expense for the
three
months ended in Mar. 2026 was 円13,097 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was 円49,492 Mil.
Fukuda Denshi Co's quarterly Other Operating Expense
declined
from Sep. 2025 (円12,170 Mil) to Dec. 2025 (円12,004 Mil) but then
increased
from Dec. 2025 (円12,004 Mil) to Mar. 2026 (円13,097 Mil).
Fukuda Denshi Co's annual Other Operating Expense
increased
from Mar. 2024 (円47,941 Mil) to Mar. 2025 (円47,942 Mil) and
increased
from Mar. 2025 (円47,942 Mil) to Mar. 2026 (円49,914 Mil).
Fukuda Denshi Co Other Operating Expense Related Terms
Fukuda Denshi Co Other Operating Expense Historical Data
* Premium members only.
The historical data trend for Fukuda Denshi Co's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円49,492 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of 円49,492 Mil mean?
Fukuda Denshi Co (TSE:6960) has a Other Operating Expense of 円49,492 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Fukuda Denshi Co and its competitors.
Is Fukuda Denshi Co's Other Operating Expense too high?
Fukuda Denshi Co's current Other Operating Expense is 円49,492 Mil. Overall, Fukuda Denshi Co has a GF Score™ of 85/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fukuda Denshi Co's Other Operating Expense compare to ABT and SYK?
Fukuda Denshi Co's Other Operating Expense of 円49,492 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Medical Devices & Instruments company?
A good Other Operating Expense depends on the Medical Devices & Instruments industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Fukuda Denshi Co and its competitors. Fukuda Denshi Co's current Other Operating Expense is 円49,492 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fukuda Denshi Co stock overvalued right now?
Based on GuruFocus' analysis, Fukuda Denshi Co (TSE:6960) is currently considered Significantly Overvalued. The stock's GF Value™ is 円7,347.11, compared to a current price of 円11,870.00 — trading 61.6% above its estimated fair value. The current Other Operating Expense is 円49,492 Mil. Fukuda Denshi Co's overall GF Score™ is 85/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Fukuda Denshi Co (TSE:6960), the current Other Operating Expense is 円49,492 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fukuda Denshi Co (TSE:6960) Overvalued in 2026?
Based on GuruFocus' analysis, Fukuda Denshi Co stock appears to be overvalued.
The current stock price of 円11,870.00 is trading 61.6% above its estimated GF Value™ of 円7,347.11.
GuruFocus considers Fukuda Denshi Co to be Significantly Overvalued.
Key valuation signals for TSE:6960:
Other Operating Expense: 円49,492 Mil
GF Value™: 円7,347.11 vs. price of 円11,870.00 (61.6% above fair value)
No single metric tells the full story. See the TSE:6960 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fukuda Denshi Co Ltd develops and manufactures medical electronic equipment. The firm operates in four segments: physiological diagnostic equipment, patient monitoring equipment, medical treatment equipment, and consumables and other products. The physiological diagnostic equipment business sells electrocardiographs, vascular screening systems, and blood cell counters. The patient monitoring equipment segment sells patient monitors and transmitters. The medical treatment equipment segment contributes the largest proportion of revenue and sells pacemakers and medical equipment for home treatment. The consumables and other products segment sells disposable electrodes and consumables used for the firm's devices. Fukuda Denshi generates the vast majority of its sales in Japan.
85GF Score
Get the complete analysis for TSE:6960
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6960 has been successfully added to your 
